Disrupted gut barriers in SLE allow bacterial translocation, as evidenced by Lactobacillus reuteri, which is found in internal organs of SLE mouse models, whereas elevated gut barrier markers such as fecal albumin in patients further link increased intestinal permeability to disease progression [43, 44, 45]. This evidence concerns the gene ALB and systemic lupus erythematosus.